Is the World Health Organization-recommended dose of pralidoxime effective in the treatment of organophosphorus poisoning? A randomized, double-blinded and placebo-controlled trial

BACKGROUND: Organophosphorus poisoning (OPP) is a major global public health problem. Pralidoxime has been used in a complimentary role to atropine for the management of OPP. World Health Organization (WHO) recommends use of pralidoxime but studies regarding its role have been inconclusive, ranging...

Descripción completa

Detalles Bibliográficos
Autores principales: Syed, Sumaya, Gurcoo, Showkat Ahmad, Farooqui, Ayaz Khalid, Nisa, Waqarul, Sofi, Khalid, Wani, Tariq M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279350/
https://www.ncbi.nlm.nih.gov/pubmed/25558199
http://dx.doi.org/10.4103/1658-354X.146306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279350/
https://www.ncbi.nlm.nih.gov/pubmed/25558199
http://dx.doi.org/10.4103/1658-354X.146306

Ejemplares similares